0000899243-20-030338.txt : 20201103
0000899243-20-030338.hdr.sgml : 20201103
20201103205337
ACCESSION NUMBER: 0000899243-20-030338
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201026
FILED AS OF DATE: 20201103
DATE AS OF CHANGE: 20201103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BIOTECH TARGET N V
CENTRAL INDEX KEY: 0001259870
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 201284993
MAIL ADDRESS:
STREET 1: ARA HILL TOP BUILDING, UNIT A-5
STREET 2: PLETTERIJWEG OOST 1, CURACAO
CITY: WILLEMSTAD
STATE: P8
ZIP: 000000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BB BIOTECH AG
CENTRAL INDEX KEY: 0000924223
STATE OF INCORPORATION: V8
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32979
FILM NUMBER: 201284994
BUSINESS ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
BUSINESS PHONE: 411724 59 59
MAIL ADDRESS:
STREET 1: SCHWERTSTRASSE 6
CITY: SCHAFFHAUSEN
STATE: V8
ZIP: 8200
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Molecular Templates, Inc.
CENTRAL INDEX KEY: 0001183765
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943409596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
BUSINESS PHONE: 512 896 1555
MAIL ADDRESS:
STREET 1: 9301 AMBERGLEN BLVD
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78729
FORMER COMPANY:
FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20020828
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2020-10-26
0
0001183765
Molecular Templates, Inc.
MTEM
0001259870
BIOTECH TARGET N V
ARA HILL TOP BUILDING, UNIT A-5,
PLETTERIJWEG OOST 1
CURACAO
P8
00000
NETHERLANDS ANTILLES
0
0
1
0
0000924223
BB BIOTECH AG
SCHWERTSTRASSE 6
SCHAFFHAUSEN
V8
CH-8200
SWITZERLAND
0
0
1
0
Common Stock
5069996
D
Biotech Target N.V. is a wholly-owned subsidiary of BB Biotech AG. Accordingly, BB Biotech AG may be deemed to be the indirect beneficial owner of the securities of Molecular Templates, Inc. held directly or indirectly by Biotech Target N.V. The Form 3 is jointly filed by BB Biotech AG and Biotech Target N.V.
/s/ Martin Gubler
2020-11-02
/s/ Ivo Betschart
2020-11-02